Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Hydroxycarbamide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydroxycarbamide 500mg capsules
0801050P0AAAAAA
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | 18,497 |
|
Hydroxycarbamide 500mg/5ml oral solution sugar free
0801050P0AAAEAE
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | 209 |
|
Hydroxycarbamide 500mg/5ml oral suspension
0801050P0AAADAD
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | 17 |
|
Hydroxycarbamide 500mg/5ml oral solution
0801050P0AAABAB
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | 11 |
|
Hydroxycarbamide 300mg capsules
0801050P0AAACAC
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.